Can-Fite BioPharma Ltd. (CANF) Financials
CANF Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Dec. 31, 2025 | 9.5 million | 3.9 million |
| Sept. 30, 2025 | 9.5 million | 3.9 million |
| June 30, 2025 | 7.7 million | 3.5 million |
| March 31, 2025 | 7.7 million | 3.5 million |
CANF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Dec. 31, 2025 | -2.1 million | 44500 |
| Sept. 30, 2025 | -2.1 million | 44500 |
| June 30, 2025 | -2.4 million | 125500 |
| March 31, 2025 | -2.4 million | 125500 |
CANF Net Income
No data available :(
CANF Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Dec. 31, 2025 | 8.5 million | - | 71000 |
| Sept. 30, 2025 | 8.5 million | - | 71000 |
| June 30, 2025 | 6.5 million | - | 90000 |
| March 31, 2025 | 6.5 million | - | 90000 |
CANF Shares Outstanding
CANF Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Dec. 31, 2025 | 500 | 1.8 million | 798000 | - |
| Sept. 30, 2025 | 500 | 1.8 million | 798000 | - |
| June 30, 2025 | 500 | 1.5 million | 1.0 million | - |
| March 31, 2025 | 500 | 1.5 million | 1.0 million | - |
CANF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Dec. 31, 2025 | 101500 | - |
| Sept. 30, 2025 | 101500 | - |
| June 30, 2025 | 101000 | - |
| March 31, 2025 | 101000 | - |
CANF
Price: $2.30
52 week price:
Earnings Per Share: -10.75 USD
Exchange: ASE
Sector: Healthcare
Industry: Biotechnology
Country: Israel
Volume: 29900
Market Capitalization: 4.8 million